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Abstract Eucaryotic expression vectors bearing a 1.4 kb eDNA 
encoding the 4 repeat isoform of human tau, tau441, in either the 
sense or anti-sense orientation with respect o a cytomegalovirus 
(CMV) promoter were constructed. The resulting constructs were 
used to transiently express tau in Chinese Hamster Ovary cells 
and to generate non-neuronal stable cell lines. Immunocytochem- 
ical studies of these cells show that tau is expressed in the sense 
but not the anti-sense or vector containing lines. Some of the cells 
expressing tau showed fine elongated processes which were 
stained by tau antibodies. The general tau immunostaining pat- 
tern appeared diffuse and punctuate. The expressed tau was seen 
both unbound and bound to microtubules. In some cells labeling 
with antibodies that specifically recognize hyperphosphorylation 
of tau was observed. The size of this population increased with 
increasing numbers of cell passages. However, no increase in 
steady-state tubulin level was observed following tau44~ expres- 
sion. These studies show that tau can accumulate in the cells 
without a concomitant increase in tubulin. 
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1. Introduction 
Tau is one of the two major microtubule associated proteins 
(MAPs) found in neurons. In normal adult human brain there 
are six molecular species of tau. These isoforrns are products 
of a single gene and are generated by alternate splicing [1]. The 
six adult human tau isoforms differ from one another by having 
three or four tubulin binding repeat domains of 31 32 amino 
acids in the carboxy terminal half of the protein [2] and by the 
presence or absence of one or two identical inserts of 29 amino 
acids, each near its amino terminal end. 
Tau stimulates microtubule assembly by polymerizing with 
tubulin and maintains the microtubule structure [3,4]. In addi- 
tion, tau is a phosphoprotein and its biological activity is regu- 
lated by its degree of phosphorylation [5,6]. In Alzheimer's 
disease (AD) tau is abnormally hyperphosphorylated. It is this 
form that accumulates in affected neurons [7-10]. The abnor- 
mally phosphorylated tau isolated from AD brain is biologi- 
cally inactive, but on dephosphorylation itsmicrotubule assem- 
bly promoting activity can be restored to near normal levels 
[6,11], Under microtubule assembly conditions, abnormally 
phosphorylated tau inhibits the assembly of microtubules; this 
inhibition appears to be caused by the binding of the abnormal 
tau to normal tau, preventing the latter to interact with tubulin 
[6]. 
The lack of a cell or animal model system for Alzheimer 
disease has considerably hampered efforts to elucidate the pa- 
thophysiological mechanisms that lead to the deterioration and 
ultimately the death of neurons in AD brains. In this paper we 
show that, under the control of cytomegalovirus (CMV) pro- 
moter, a human tau441 eDNA can be stably expressed in Chi- 
nese Hamster Ovary (CHO) cells; these cells do not express 
endogenous tau. Some of the expressed tau is phosphorylated, 
is not associated with microtubules and accumulates in the 
transfected cells. The expression of tau in CHO cells does not 
result in any detectable increase in the levels of tubulin. 
2. Materials and methods 
2.1. Construction oJ expression plasmids 
The prokaryotic expression vector pRK172, bearing the four repeat 
recombinant isoform of human tau441, was kindly provided by Dr. 
Michel Goedert [1]. The entire 1.4 kb tau44~ insert from this plasmid was 
amplified by PCR using a 5' primer, 5'-ATGGCTGAGCCCCGCCA- 
GGAGTT-Y, coding for the first 23 bases in the human tau44~, eDNA 
sequence and a 3' primer, 5'-TAATGGACCGCCCAGGGGCCT-Y, 
complementary to the last 23 bases of the coding sequence and subse- 
quently subcloned into pCRVMII (Invitrogen Corp., San Diego, CA). 
Clones with tau in both the sense (TA-T10), and the anti-sense (TA-T8) 
orientation with respect o the pCR TM II Sp6 promoter were identified 
by restriction analysis using Sacl. Restriction enzyme analysis with 
Sacl revealed a small fragment of 328 bp and a larger fragment of 1,137 
bp for the sense and anti-sense clones respectively. Tau44~ and anti- 
tau441 eucaryotic expression vectors (Fig. 1) were constructed by insert- 
ing the BamHI/Xhol fragments from TA-T10 and TA-T8 into 
pCDNA3 (Invitrogen Corp). The resulting plasmids, pCDNA3-T10 
and pCDNA3-T8 were characterized by restriction analysis and PCR 
(Fig. lc,i iii). Transient and stable transfection studies (see below) were 
performed with plasmid DNAs purified using the Wizard-Prep method 
(Promega Corp., Madison, WI) according to the manufacturer's proto- 
col. 
2.2. Cell culture and geneticin, G418 selection 
CHO cells were maintained in RPMI 1640 (Gibco-BRL, Gaithers- 
burg, MD), supplemented with 10% fetal calf serum, 100 pg/ml penicil- 
lin G, and 100,ug/ml streptomycin i  a 37°C humidified CO2 incubator. 
Approximatley 1 x 10 6 cells were plated on 35 mm culture dish two days 
prior to transfection. Ten micrograms of DNA-lipofectin (Gibco-BR L, 
Gaithersburg, MD) complex was prepared and overlaid on cells con- 
taining serum- and antibiotic-free media. After 20 hr the cells were fed 
with fresh media supplemented with 10% fetal calf serum. After two 
days the cells were either harvested for transient expression analysis or 
subjected to 400/.tg/ml of geneticin G418 (Gibco-BRL, Gaithersburg, 
MD) to select ['or stable transfectants. After three weeks ome neomycin 
resistant colonies were formed. 
*Corresponding author. Fax: (1) (718) 494 1080. 
2.3. Immunocytochemistt T 
Transfected CHO cells were washed twice with PBS (phosphate- 
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buffered saline: 200 mM NaC1, 10 mM Na2HPO 4, pH 7.0) at 37°C and 
fixed for 5 min at 37°C with 4% paraformaldehyde and 0.1% Triton 
X-100 in 100 mM PIPES, 5 mM EGTA, 2 mM MgC12. In some cases 
cells were first extracted with 0.1% Triton X-100 for 1-2 min at 37°C 
after incubating in a microtubule-stabilizing buffer (100 mM PIPES, 5 
mM EGTA, 2 mM MgCI:, 2 M glycerol, pH 6.8) [12,13]. After fixation, 
the cells were overlaid with ~ -20°C cold methanol for five minutes. The 
cells were washed three times with PBS, blocked with 2% BSA (bovine 
serum albumin) in TBS (Tris-buffered saline: 200 mM NaCI, 50 mM 
Tris, pH 7.6) buffer and incubated with the primary antibodies over- 
night in a humid chamber. Unbound antibody was removed by three 
washes with PBS. Bound antibody was detected by incubation for one 
hour at 37°C with pre-absorbed fluorescein isothiocyanate (FITC)- 
conjugated goat anti-rabbit or anti-mouse IgG, respectively. Secondary 
antibodies were diluted 1 : 500 in TBS/BSA. Primary antibodies used 
were the mouse monoclonal tau antibodies Tau-1 (ascites, 1 : 10,000) 
[14], AT8 (1: 100) (Immunogenetics, Ghent, Belgium) and PHF-1 (cul- 
ture supernatant, 1 : 500), [15], rabbit polyclonal anti-tau antibody 92e 
(1:5000) [16] and mouse monoclonal antibody DMIA to ~ tubulin 
(1:500) (Sigma, St. Louis, MO). Coverslips were mounted in Vecta 
shield (Vector Laboratories, Inc., Burlingame, CA). The cells were 
examined and photographed with a Zeiss Axioskop microscope 
equipped for epifluorescence (Carl Zeiss, Inc., Thornwood, NY). 
2.4. SDS-PA GE and immunoblotting 
Control and transfected CHO cells were harvested, washed in PBS 
and centrifuged at 1000 x g for 5 min at 40°C. The pellet was suspended 
in 500 #1 lysis buffer (2%, w/v, SDS, 2%, v/v, 2-mercaptoethanol), 
sonicated for 5 min and boiled for 10 min. Total protein was measured 
using the modified Lowry method [17]. Proteins were resolved by SDS- 
PAGE on slab gels (80 × 60 x 0.75 mm), using a linear polyacrylamide 
gradient (7.5-15%) and the Laemmli buffer system [18]. 100#g of total 
protein was loaded in each well. After electrophoresis, protein and 
prestained high molecular weight protein standards (Gibco-BRL, 
Gaithersburg, MD) were transferred to Immobilon membranes (0.45 
#m; Millipore, Bedford, MA) at 105 V for 1 h and immunostained as 
previously described [7]. In some cases, blots were dephosphorylated 
with 149 U/ml alkaline phosphatase (Boehringer Mannheim, Indianap- 
olis, IN) [7], for 3 h at 37°C. Antibody binding was either detected with 
the peroxidase anti-peroxidase method [19] or with alkaline phosphat- 
ase conjugated secondary antibodies. 
3. Results 
As a first step towards developing a cell culture model in 
which the effect of various modulat ing factors on the largest 
isoform of human tau could be examined, tau44m cDNA was 
cloned into the eukaryotic expression vector pCDNA3.  This 
vector contains a constitutively active human cytomegalovirus 
promoter, which is known to drive high levels of heterologous 
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Fig. 1. Schematic diagram of tau pCDNA3 constructs and analysis of pCDNA3-tau44L clones. (a) Sense orientation; (b) Anti-sense orientation; (c) 
Selected miniprep DNAs containing the putative tau44~ clones (lanes 2,3) and pCDNA-3 vector (lane 4) were analyzed for the presence of (i) EeoRI 
and (ii) NdeI and XhoI sites. The orientation of the clones (iii) was confirmed by PCR amplification of either, the complete CMV promoter (lanes 
2-5) or CMV promoter and tau44~ (lanes 6-9). Lanes 2,6, vector; lanes 3,7, sense; lanes 4,8, anti-sense; lanes, 5,9, control-pRC/CMV (lanes 2 5 CMV 
primers, lanes 6-9 CMV and tau44~ primers). 
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Fig. 2. Tau44~ expression in CHO cells. Immunofluorescence staining of (a) transient and (b-g) stably transfected CHO cells was detected using (a,b) 
mAb Tau-1, (c) polyclonal antibody 92e and (d) mAb PHF-I. (e-g) Endogenous a-tubulin expression in CHO cells transfected stably with various 
constructs; tubulin expression was detected with mAb DM1A; (e) anti-sense totau44~, (f) tau~ sense and (g) vector alone. Insert in: (a) shows a cell 
with a fine long process, (b) shows punctuate immunostaining of tau, and (b') shows the binding of tau to the cytoskeleton i  Triton X-100 extracted 
cells. 
gene expression in a wide variety of mammalian cell lines. The 
full length 1.4 kb, four repeat isoform, of human tau was cloned 
and screened (Fig. 1) for a sense and an anti-sense clone. 
We had previously observed that CMV-driven chloram- 
phenicol acetyltransferase (CAT) gene constructs were ex- 
tremely active in CHO cells 48 h following transfection (data 
not shown). Therefore, we initially examined whether human 
tau44~ could be transiently expressed in CHO cells following the 
same protocol. Forty hours after transfection many cells were 
rounded though a small percentage had flattened. A few cells 
had small processes. Tau expression was not detected by im- 
munoblotting but immunofluorescence studies howed punctu- 
ate staining with mAb Tau-1 (Fig. 2a) in tau441 transfected 
cells. 
For stable transfection, cells were selected on the basis of 
their resistance to G418. Cells expressing tau44~ were large and 
there were occasional giant cells with large nuclei and very long 
processes. These cells stained positive with tau antibodies. In 
general, tau expressing cells took a longer time to reach conflu- 
ence but the expression of tau did not affect the viability of the 
cells. Immunofluorescence staining with antibodies to tau, as 
expected, did not show any immunoreactivity n untransfected 
CHO cells or cells transfected with the vector or anti-sense. 
Therefore, it was easy to screen the tau expressing cells. 
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Fig. 3. Analysis of protein expression i  CHO cells stably transfected 
with various constructs. Samples were electrophoresed and transferred 
to Immobilon. One half of the blot was stained with Coomassie blue 
(b); the other half was immunolabeled with mAb DM 1A to tubulin (a). 
Twenty and 50/~g of protein/lane were applied for the Coomassie blue 
and immunostaining, respectively. Lanes 1 and 6, vector; lanes 2 and 
5, anti-sense; lanes 3 and 4, sense. 
Cells transfected with tau~ in the sense orientation were 
positively stained with tau antibodies, 92e (Fig. 2c), to total tau 
and Tau-1 (Fig. 2b) which only labels tau that is not 
phosphorylated at Ser-199/202 [7]. The intensity of labeling 
varied from one cell to another and was independent of the 
number of passages. Generally, the immunostaining was diffuse 
and punctuate. Some of the cells expressing tau showed fine 
elongated processes which were tau positive along with the cell 
body. Some cells showed more than one process while others 
had wider and shorter cytoplasmic extensions. Several cells 
were polynucleated. In addition to apparently normal tau, 
some cells also exhibited brightly immunofluorescent clusters 
in the cytoplasm when stained with antibodies AT8 (data not 
shown) or PHF-1 (Fig. 2d), indicating that tau in some selected 
cells is hyperphosphorylated at Ser-199/202 and/or Ser-396. 
The number of cells staining positively with mAb PHF-1 and 
AT8 increased with subsequent passages. However, the in- 
crease seen with mAb PHF-1 appeared considerably smaller 
than that with AT8. Monoclonal antibody DMIA, to cz-tubulin 
did not show any detectable differences in staining the microtu- 
bule network between the control and the tau441 expressing cells 
(Fig. 2e-g). This was confirmed by immunoblot analysis 
(Fig. 3). 
To assess whether any of the tau expressed in stably trans- 
fected CHO cells was bound to microtubules, the soluble cyto- 
plasmic proteins were removed by Triton X-100 extraction 
prior to formaldehyde fixation. While strong staining of the 
microtubule network with tubulin antibodies was readily ob- 
served, labeling with Tau-1 was only observed in a few cells 
(Fig. 2b'). These immunocytochemical studies indicate that in 
the transfected cells the tau is expressed both unbound and 
bound to microtubules. 
On immunoblots of cell lysates mAb Tau-1 stained one major 
band with an apparent Mr of around 66,000 and a series of 
minor bands, most probably degradative products of tau (Fig. 
4). Dephosphorylation f the blot prior to application of the 
antibody did not result in an increase of the staining intensity. 
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Only weak staining of the tau band was observed with antibod- 
ies PHF-1 (data not shown) and AT8 (Fig. 4). 
4. Discussion 
Previous tudies have suggested that MAP2 and tau are both 
synthesized during neuronal differentiation [20] and are impor- 
tant for maintaining the microtubule array characteristic of 
neuronal morphology [21]. Transfection studies have demon- 
strated that expression of these proteins in non-neuronal cells 
stabilizes and, in some cases, promotes bundling of microtu- 
bules [12,22-25]. 
In the present study CHO cells were stably transfected with 
human tau44~ cDNA. Tau expression was observed both im- 
munocytochemically and by Western blotting after many cell 
passages. The detection of tau expression in cells transfected 
with tau44~ in the sense but not the anti-sense-orientation, or 
cells transfected with vector alone demonstrates the successful 
tranfection of tau441 in Cl iO cells. 
CHO cells are normally either round or spindle shaped and 
are relatively simple, non-differentiated cells. These non-neu- 
ronal cells express low levels of a heat stable MAP-4 like pro- 
tein [26]. On transfection with taut1 the CHO cells developed 
one or more processes, ome wide and short and some thin and 
several cell lengths long. The development of the processes by 
the transfected cells probably was due to increased stabilization 
of microtubules produced by a combination of the expressed 
tau and the endogenous MAPS. These findings are consistent 
with those of Esmaeli-Azad, et al. [13] who showed that the 
neurite outgrowth was directly proportional to the levels of tau 
expression in PC 12 cells transfected with tau. 
Immunocytochemical staining of the transfected cells, and 
these cells after extraction and removal of the cytoplasmic non- 
cytoskeletal proteins revealed a discrete labeling of the cy- 
toskeleton by antibodies to tubulin. In contrast, identically 
treated transfected cells, when labeled with tau antibodies, re- 
vealed less discrete cytoskeletal staining, suggesting that only 
a small amount of the tau in the transfected cells was associated 
with microtubules. No increase in bundling of microtubules 
was apparent in the transfected cells as determined by im- 
munocytochemical staining with antibodies to tubulin; the 
sense, anti-sense and the vector alone transfected cells looked 
similar. In a previous tudy transfection of Swiss 3T3 cells with 
tau also did not result in any increase in microtubule bundling 
[271. 
Western blots of the cell lysates developed with tubulin anti- 
bodies failed to reveal any apparent increase in the expression 
of tubulin. Furthermore, both immunocytochemical and West- 
ern blot analysis of the tau,~, transfected cells developed with 
monoclonal antibodies to phosphoepitopes of tau revealed that 
some of the expressed tau became phosphorylated at Ser-199/ 
Ser-202 and/or Ser-396. The signal for the phosphorylated pro- 
tein appeared to increase with increasing number of passages. 
It cannot be determined with the antibodies available to what 
degree the transfected tau might be phosphorylated at sites 
other than Ser-199/202 and Ser-396. These studies uggest that 
the autoregulation of microtubules in cells might not only in- 
volve the changes in the synthesis of tubulin as proposed by 
Cleveland [28], but also the phosphorylation of tam hyper- 
phosphorylated tau is known not to bind to tubulin/microtu- 
bules [5,6,11]. The tau in excess of that required for the mainte- 
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Fig. 4. Immunolabeling onWestern blot of human tau441 stably trans- 
fected CHO cell lysates. The protein samples were electrophoresed on 
a 80 x 60 x 0.75 mm SDS-polyacrylamide gel(7.5-15% acrylamide gra- 
dient) and transferred toImmobilon and immunolabeled with antibod- 
ies Tau-1 and AT8. *Indicates blot that was treated with alkaline 
phosphatase prior to incubation with the antibodies, mAb Tau-1 only 
reacts with tau that is not phosphorylated at Ser-199/202 whereas AT8 
recognizes tau epitopes phosphorylated at Ser-199/202. Lanes 2,3,6: cell 
lysate from transfected cells and lane I from untransfected control cells, 
100 ¢tg protein in lanes 1,2 and 3; 150 ~g protein in lane 6. Lane 4: 
purified human brain tau, 2.5/lg protein. Lane 5: hyperphosphorylated 
AD tau, 0.5 fig protein. Like untransfected cells (lane 1), vector alone 
and antisense transfected cells were also immuno-negative for tau. 
nance of microtubules may become phosphorylated and may 
accumulate without involving an increase in the synthesis of 
tubulin. While this manuscript was in preparation, Barlow, et 
al. [29] also reported an absence of any changes in the levels of 
tubulin in CHO cells transfected with tau or MAP4; these 
investigators did not study the state of phosphorylation of tau 
in the transfected cells. 
The accumulation of tau unbound to microtubules in the 
tau44~ transfected CHO cells appears to be consistent with the 
accumulation of abnormally hyperphosphorylated au seen in 
affected neurons in the brain of patients with Alzheimer dis- 
ease, and inconsistent with the autoregulatory model involving 
changes in the expression of tubulin. 
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